Alex Mann

2.0k total citations
23 papers, 453 citations indexed

About

Alex Mann is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Alex Mann has authored 23 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 9 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Alex Mann's work include Influenza Virus Research Studies (11 papers), Respiratory viral infections research (9 papers) and Immune Response and Inflammation (4 papers). Alex Mann is often cited by papers focused on Influenza Virus Research Studies (11 papers), Respiratory viral infections research (9 papers) and Immune Response and Inflammation (4 papers). Alex Mann collaborates with scholars based in United Kingdom, United States and Netherlands. Alex Mann's co-authors include Rob Lambkin‐Williams, John Oxford, Anthony Gilbert, Jan Willem van der Laan, Alison Boyers, Carla Herberts, Shobana Balasingam, Nigel J. Dimmock, Anthony C. Marriott and Ganesh Balaratnam and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PLoS Pathogens.

In The Last Decade

Alex Mann

22 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alex Mann United Kingdom	11	262	140	125	68	52	23	453
Anne‐Marte Bakken Kran Norway	15	207 0.8×	301 2.1×	82 0.7×	82 1.2×	29 0.6×	36	518
Kristina Træholt Franck Denmark	13	135 0.5×	252 1.8×	128 1.0×	60 0.9×	32 0.6×	28	548
Hebah A. Al-Khatib Qatar	14	157 0.6×	232 1.7×	51 0.4×	66 1.0×	22 0.4×	27	403
Aripuanã Sakurada Aranha Watanabe Brazil	11	251 1.0×	164 1.2×	31 0.2×	25 0.4×	34 0.7×	37	368
Michelle M. Packard United States	7	169 0.6×	575 4.1×	63 0.5×	79 1.2×	26 0.5×	11	760
Ernst C. Soethout Netherlands	10	273 1.0×	104 0.7×	207 1.7×	98 1.4×	19 0.4×	16	480
Aldo Barrera Chile	9	177 0.7×	90 0.6×	57 0.5×	121 1.8×	14 0.3×	12	337
Ronald Jacobi Netherlands	12	214 0.8×	96 0.7×	152 1.2×	86 1.3×	9 0.2×	23	392
Fernando Couto Motta Brazil	12	202 0.8×	272 1.9×	20 0.2×	109 1.6×	23 0.4×	37	488
Nathaniel D. Lambert United States	13	368 1.4×	200 1.4×	194 1.6×	144 2.1×	20 0.4×	15	618

Countries citing papers authored by Alex Mann

Since Specialization

Citations

This map shows the geographic impact of Alex Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Mann more than expected).

Fields of papers citing papers by Alex Mann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Mann. The network helps show where Alex Mann may publish in the future.

Co-authorship network of co-authors of Alex Mann

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Mann. A scholar is included among the top collaborators of Alex Mann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Mann. Alex Mann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lindert, Kelly, Alex Mann, Anita Geevarughese, et al.. (2025). Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza Vaccine. NEJM Evidence. 4(12). EVIDoa2500087–EVIDoa2500087. 1 indexed citations

Lerman, Imanuel, Harold Silverman, Alex Mann, et al.. (2025). Next generation bioelectronic medicine: making the case for non-invasive closed-loop autonomic neuromodulation. PubMed. 11(1). 1–1. 7 indexed citations

Cheng, Mickie, Alex Mann, Brian M. Maas, et al.. (2025). A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus. Pulmonary Therapy. 11(2). 285–304. 1 indexed citations

Equils, Ozlem, Shawn Flanagan, Johan Vingerhoets, et al.. (2025). 573. CD388, a Novel Drug-Fc Conjugate (DFC), Demonstrates Prophylactic Activity in an Influenza Human Challenge Model. Open Forum Infectious Diseases. 12(Supplement_1).

Trender, William, Peter J. Hellyer, Ben Killingley, et al.. (2024). Changes in memory and cognition during the SARS-CoV-2 human challenge study. EClinicalMedicine. 76. 102842–102842. 9 indexed citations

Wagstaffe, Helen R., Ryan S. Thwaites, Arnold Reynaldi, et al.. (2024). Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults. Science Immunology. 9(92). eadj9285–eadj9285. 21 indexed citations

Zhou, Jie, Anika Singanayagam, Niluka Goonawardane, et al.. (2023). Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study. The Lancet Microbe. 4(8). e579–e590. 35 indexed citations

Mesquita, P. Jacob Bueno de, Jonathan S. Nguyen‐Van‐Tam, Ben Killingley, et al.. (2020). Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected cases. Influenza and Other Respiratory Viruses. 15(1). 154–163. 5 indexed citations

Nguyen‐Van‐Tam, Jonathan S., Ben Killingley, Joanne Enstone, et al.. (2020). Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environment. PLoS Pathogens. 16(7). e1008704–e1008704. 18 indexed citations

10.

Nguyen‐Van‐Tam, Jonathan S., Ben Killingley, Joanne Enstone, et al.. (2019). Minimal Transmission in an Influenza A (H3N2) Human Challenge-Transmission Model with Exposure Events in a Controlled Environment. SSRN Electronic Journal. 1 indexed citations

11.

Schecklmann, Martin, Alex Mann, Berthold Langguth, et al.. (2017). The Temporal Muscle of the Head Can Cause Artifacts in Optical Imaging Studies with Functional Near-Infrared Spectroscopy. Frontiers in Human Neuroscience. 11. 456–456. 27 indexed citations

12.

Mori, Julie, Andrew Catchpole, Edward J. Murray, et al.. (2016). A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model. PLoS ONE. 11(12). e0166113–e0166113. 5 indexed citations

13.

Noulin, Nicolas, Andrew Catchpole, Hosnieh Fathi, et al.. (2016). Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model. PLoS ONE. 11(1). e0145902–e0145902. 9 indexed citations

14.

Lambkin‐Williams, Rob, Colin Gelder, Corey P. Mallett, et al.. (2016). An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection. PLoS ONE. 11(12). e0163089–e0163089. 24 indexed citations

15.

Pleguezuelos, Olga, Stuart Robinson, Ana M. Fernández, et al.. (2015). A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans. Clinical and Vaccine Immunology. 22(7). 828–835. 55 indexed citations

16.

Mann, Alex, Nicolas Noulin, Andrew Catchpole, et al.. (2014). Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge. PLoS ONE. 9(5). e93761–e93761. 27 indexed citations

17.

Romanova, Julia, Brigitte M. Krenn, Markus Wolschek, et al.. (2009). Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine. PLoS ONE. 4(6). e5984–e5984. 57 indexed citations

18.

Laan, Jan Willem van der, Carla Herberts, Rob Lambkin‐Williams, et al.. (2008). Animal models in influenza vaccine testing. Expert Review of Vaccines. 7(6). 783–793. 71 indexed citations

19.

Mann, Alex, Anthony C. Marriott, Shobana Balasingam, et al.. (2006). Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection. Vaccine. 24(20). 4290–4296. 40 indexed citations

20.

Blizzard, Robert M., et al.. (1994). The Gospel Oak project 1987-1990: provision and use of community services.. PubMed. 25(4). 142–6. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact